aod9604 research Aod 9604 - 5mg AOD 9604 (5mg) - Nutritomic

Known and theoretical safety concerns include: Retatrutide (and the GLP-1 receptor agonist class): Nausea, vomiting, diarrhoea, and reduced appetite are the most commonly reported side effects

Endocrine Journal

Any references to biological activity are provided strictly for research context and must not be interpreted as claims of safety, efficacy, or intended human use

It is not medical advice and not a treatment recommendation

B12 is crucial in brain function, nerve tissue health, and red blood cell production

Reported biochemical potency against human NNMT is in the low-micromolar range with cellular EC values in the low-micromolar range for suppression of 1-MNA and lipogenesis, with selectivity over related methyltransferases and NAD-salvage enzymes [1,6,7]